| 标题 |
 Trevogrumab (anti-GDF8) with or without garetosmab (anti-activin A) for prevention of muscle loss during semaglutide-induced weight reduction in people with obesity (COURAGE): a two-part, phase 2, double-blind, placebo-controlled, randomised trial |
| 网址 | |
| DOI | |
| 其它 |
期刊：The Lancet 作者：Ofri Mosenzon; Julio Rosenstock; José G Raya; Joseph S Grimsby; Roberto A Calle; et al 出版日期：2026-11-12 |
| 求助人 | |
| 下载 | 暂无链接，等待应助者上传 |
PDF的下载单位、IP信息已删除
(2025-6-4)
yyh123
一谷
jin
阿吉布
无极微光
null
吃葡萄不吐葡萄皮
Maestro_S
极限001
v0id
aaaa
风吹麦浪
369ninja
YY
04d
秋风
cdercder
Criminology34
热心市民小红花
好名
OK
七听
方源
arniu2008
皖公网安备34019202002308
